|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | Gilead Sciences, Inc. | CV Therapeutics, Inc. |
| Strengthens Gilead's growing cardiovascular portfolio. In 2008, CV marketed two products that contributed to total revenues of $154m. Its more... | ||
| Biopharmaceuticals | GlaxoSmithKline | UCB |
| GSK is acquiring the rights to UCB's allergy medicines Xyzal and Zyrtec, and its epilepsy drug Keppra. The rights extend to 50 countries, more... | ||
| Biopharmaceuticals | Lundbeck Inc | Ovation Pharmaceuticals |
| Lundbeck's patents on its cash cow antidepressant Cipralex/Lexapro expire in 2012. Ovation is profitable and growing, with a broad portfolio of more... | ||
| Biopharmaceuticals | Merck & Co., Inc. | Schering-Plough Corporation |
| Creates global healthcare behemoth than can benefit from a formidable R&D capacity, a significantly broader portfolio of medicines and an more... | ||
| Biopharmaceuticals | Pfizer Inc. | Wyeth |
| Motivated by Pfizer's cholesterol drug Lipitor ($13b in sales -- 25% of Pfizer's total sales) losing patent protection in 2011, when it will more... | ||
| Biopharmaceuticals | Roche Holding AG | Genentech Inc. |
| Roche raises its offer to $46.8b to buy the 44% of Genentech it does not own already, and Genentech accepts. Roche secures rights to Genentech's more... | ||
| Biopharmaceuticals | The Medicines Company | Targanta Therapeutics Corporation |
| Adds Targanta's oritavancin, a late stage anti-infective for serious infections involving difficult-to-treat bacteria in hospitalized patients. more... | ||
| Data Management/ Healthcare IT | AMICAS, Inc. | Emageon Inc. |
| Significantly expands AMICAS' presence in the image and information management market. Combined suite will include radiology PACS, cardiology more... | ||
| Data Management/ Healthcare IT | Baxa Corporation | ForHealth Technologies, Inc. |
| Adds to Baxa a high-speed robotic system for preparing intravenous doses. Improves patient safety and the quality of health-system pharmacies. Terms more... | ||
| Data Management/ Healthcare IT | Eclipsys Corporation | Premise Corporation |
| Adds utilization management systems for bed management, bed turnover, and patient transport to Eclipsys' enterprise clinical and patient access more... | ||
| Data Management/ Healthcare IT | Intermedix Corporation | HealthWare Solutions |
| Both companies serve the emergency response sector. HWS provides electronic medical record systems to dovetail with Intermedix's billing and more... | ||
| Data Management/ Healthcare IT | Midmark Corporation | Progeny Inc. |
| Expands Midmark's technology offerings to the dental market. In addition to intraoral x-ray products, Progeny makes digital imaging sensors, more... | ||
| Diagnostics | Alpine Biomed Corporation | Stellate Systems Inc. |
| Significantly increases the size of Alpine's neuro-diagnostic business and gives it a strong foothold in the rapidly growing sleep diagnostics more... | ||
| Diagnostics | Avacta Group PLC. | TheraGenetics Limited |
| Adds molecular, personalized medicine diagnostic tests for schizophrenia, depression, bipolar disorder, Alzheimer’s disease and ADHD (attention more... | ||
| Diagnostics | Beckman Coulter, Inc. | Olympus Corporation |
| Expands Beckman Coulter's worldwide position in clinical chemistry and immunoassay solutions especially in larger hospital laboratories (where more... | ||
| Diagnostics | Gen-Probe Incorporated | Tepnel Life Sciences, PLC |
| Buying Tepnel will provide immediate access to attractive growth opportunities in transplant diagnostics, genetic testing and pharmaceutical more... | ||
| Diagnostics | Inverness Medical Innovations Inc. | ACON Laboratories Inc. |
| In 06, Inverness acquired Acon’s rapid diagnostics business for the U.S., Canada and Europe, and agreed if milestones were reached to acquire more... | ||
| Diagnostics | Millipore Corporation | Guava Technologies |
| With Guava's instruments, Millipore's flow cytometry platform is more accessible to cell biologists and researchers outside of central labs. more... | ||
| Diagnostics | Roche Holding AG | innovatis AG |
| innovatis focuses on cell counting, viability testing, and cell function analysis in research as well as bioproduction. The deal widens Roche's more... | ||
| Distribution | Henry Schein, Inc. | Noviko, DNA Anthos Impianti and Medka |
| Noviko is the leading distributor of veterinary supplies in the Czech Republic (sales - $70m). DNA Anthos Impianti is the Italian distribution arm of more... | ||
| Distribution | Henry Schein, Inc. | Ortho Organizers |
| Helps to further Schein's orthodontic platform. Ortho's sales are about $30m. Terms not more... | ||
| Distribution | Welch Allyn, Inc. | MD International |
| Positions Welch Allyn for greater opportunities in emerging markets in South and Central America, Mexico and the Caribbean. Terms not more... | ||
| Medical Devices | Abbott Laboratories | Advanced Medical Optics Inc. |
| In this diversification play, Abbott sees cataract surgery (50% of AMO's business) growing with the aging baby boomers. The laser vision more... | ||
| Medical Devices | Aspen Surgical Products Holding, Inc. | ConvaTec |
| The divestiture was a requirement of the European Commission following the acquisition of ConvaTec by Nordic Capital and Avista Capital Partners. more... | ||
| Medical Devices | Boston Scientific Corporation | Labcoat Limited |
| Labcoat developed a novel technology for coating drug-eluting stents that reduces the amount of polymer and drug to which the vessel wall is exposed, more... | ||
| Medical Devices | Endo Pharmaceuticals Holdings, Inc. | Indevus Pharmaceuticals, Inc. |
| Allows Endo to expand beyond pain management with novel therapies for urology and endocrinology. The combined company will market nine products more... | ||
| Medical Devices | Integra LifeSciences Holdings Corporation | Minnesota Scientific, Inc. (d/b/a Omni-Tract Surgical) |
| Will integrate Omni-Tract's product lines into its combined offering of JARIT®, Padgett™, R&B Redmond™, and Luxtec® lines more... | ||
| Medical Devices | Johnson & Johnson | Mentor Corporation |
| Strengthens J&J/ETHICON's presence in aesthetic and reconstructive markets, which are less sensitive to reimbursement and margin pressures. more... | ||
| Medical Devices | Medtronic, Inc. | Ablation Frontiers, Inc. |
| Following its recent acquisition of CryoCath, Medtronic broadens its range of cardiac rhythm therapies to treat atrial fibrillation. Ablation more... | ||
| Medical Devices | Medtronic, Inc. | Corevalve Inc. |
| Corevalve's technology has been implanted in 2,600 patients worldwide, but has yet to be cleared by the FDA. Rather than performing open-heart more... | ||
| Medical Devices | Medtronic, Inc. | Ventor Technologies Ltd |
| Current standard of care for patients with aortic stenosis is open-heart valve surgery. Transcatheter, minimally invasive valves offer a non-surgical more... | ||
| Medical Devices | Merit Medical Systems, Inc. | Alveolus, Inc. |
| Enables Merit to enter the gastroenterology and pulmonary stent market, which Merit believes to exceed $200m. Merit makes inflation devices, guide more... | ||
| Medical Devices | Moog Inc. | AITECS Medical UAB |
| Broadens Moog's proprietary medical device line and expands its geographic presence in the infusion therapy market. Deal value -- more... | ||
| Medical Devices | Moog Inc. | Ethox International |
| Ethox adds facilities to produce disposables for Moog's ambulatory, enteral feeding and infusion pump lines, as well as providing sterilization more... | ||
| Medical Devices | NuVasive, Inc. | Progentix Orthobiology B.V. |
| NuVasive gains access to Progentix’ synthetic bone substitutes designed to acceleratebone healing through a novel micro-structure created by a more... | ||
| Medical Devices | Small Bone Innovations, Inc. | Link Orthopedics |
| The system has been in use since 1990 with over 14,500 implantations performed worldwide. SBI plans to introduce the product in the U.S., after FDA more... | ||
| Medical Devices | ZOLL Medical Corporation | Alsius Corporation |
| Zoll will consolidate Alsius with Radiant Medical, which it bought in 2007. Both Radiant and Alsius develop catheter-based therapeutic hypothermia more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||